Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determining Optimal Treatment Intensity for Children With Language Impairment

NCT04501536 is registered in ClinicalTrials.gov with University of Texas at Austin as lead sponsor.

NCT NCT04501536
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04501536 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determining Optimal Treatment Intensity for Children With Language Impairment
Lead sponsor
University of Texas at Austin
Phase
Not applicable
Overall status
Completed
Start date
August 10, 2020
Completion date
July 31, 2025
Enrollment
59 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

language impairment